Video: Intuniv (guanfacine): Introduction and ADHD Overview
An overview of childhood Attention Deficit Disorder Hyperactivity (ADHD) and the non-stimulant treatment Intuniv (guanfacine).
Hello and welcome to "VideoScript", presented by Drugs.com.
Today in the first of three presentations, we are reviewing Intuniv, generically known as guanfacine.
Intuniv is an FDA-approved medication used as part of a treatment program to help manage the symptoms of attention deficit hyperactivity disorder, or ADHD. Intuniv is approved for use in children 6 to 17 years of age.
ADHD is a common behavioral disorder diagnosed in roughly 4 to 12 percent of school-aged children. Boys are diagnosed about three times more often than girls.
Treatment of ADHD usually involves some combination of medications, counseling, behavior modification and lifestyle changes. For young children 4 to 5 years of age, parent or teacher-administered behavioral modification is the first treatment of choice.
Patients with ADHD have difficulty maintaining attention and completing tasks, and may show signs of hyperactivity, impulsiveness, or some combination of these behaviors.
Intuniv can be used alone or in combination with stimulants, another class of medications commonly used to treat ADHD. Intuniv comes as an extended-release formulation and is given once daily.
Thank you for joining us at Drugs.com for a brief review of Intuniv. Please refer to our patient and professional information, drug interaction checker, and additional tools on Drugs.com.
Patients with a concern about the use of Intuniv should consult with their health care provider.
Visit drugs.com/Intuniv for more information
Intuniv (guanfacine): Clinical Effectiveness
Intuniv (guanfacine) clinical effectiveness to help manage the symptoms of childhood ADHD.
Intuniv (guanfacine): Common and Serious Side Effects
A brief overview of precautions and side effects for Intuniv (guanfacine).
FDA 101: Product Recalls
This FDA Consumer Update video highlights the agencys involvement in product recalls from the moment the agency is notified to successful completion of the recall.
Reducing Radiation from Medical X-rays
Medical X-rays are an important tool for diagnosing and treating diseases, but they pose a small risk from radiation. Learn what you can do to reduce the risk in this FDA Consumer Update video.
This animation shows the process of macular degeneration in the eye. The macula is the part of the retina that distinguishes fine details at the center of the field of vision. Macular degeneration results from a partial breakdown of the insulating layer between the retina and the choroid layer of blood vessels behind the retina. Macular degeneration results in the loss of central vision only.
Browse by Category
- Alzheimer's Disease
- Back Pain
- Children's Health
- Common Cold
- Erectile Dysfunction
- Exercise & Fitness
- Foot Health
- Heart Disease
- Irritable Bowel
- Joint Pain
- Men's Health
- Parkinson's Disease
- Sexual Health
- Smoking Cessation
- Women's Health